DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 3 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,451 | -27.2% | 114,041 | -19.5% | 0.00% | 0.0% |
| Q2 2023 | $1,993 | +2.7% | 141,595 | +12.8% | 0.00% | 0.0% |
| Q1 2023 | $1,940 | -29.7% | 125,569 | -25.4% | 0.00% | 0.0% |
| Q4 2022 | $2,760 | -99.9% | 168,339 | +7.8% | 0.00% | -66.7% |
| Q3 2022 | $2,890,000 | +421.7% | 156,230 | +270.7% | 0.00% | – |
| Q2 2022 | $554,000 | -66.9% | 42,148 | -76.6% | 0.00% | -100.0% |
| Q1 2022 | $1,672,000 | -39.0% | 180,374 | -35.7% | 0.00% | 0.0% |
| Q4 2021 | $2,742,000 | +26.9% | 280,566 | +341.3% | 0.00% | 0.0% |
| Q3 2021 | $2,161,000 | +94.3% | 63,579 | +109.2% | 0.00% | 0.0% |
| Q2 2021 | $1,112,000 | -72.5% | 30,393 | -66.4% | 0.00% | -50.0% |
| Q1 2021 | $4,051,000 | +33.1% | 90,367 | +69.5% | 0.00% | 0.0% |
| Q4 2020 | $3,044,000 | +186.1% | 53,310 | +157.0% | 0.00% | +100.0% |
| Q3 2020 | $1,064,000 | -58.4% | 20,747 | -51.5% | 0.00% | -50.0% |
| Q2 2020 | $2,556,000 | +7.2% | 42,800 | -26.1% | 0.00% | 0.0% |
| Q1 2020 | $2,385,000 | +22.0% | 57,920 | +84.4% | 0.00% | +100.0% |
| Q4 2019 | $1,955,000 | +71.8% | 31,408 | -6.4% | 0.00% | 0.0% |
| Q3 2019 | $1,138,000 | +426.9% | 33,548 | +250.2% | 0.00% | – |
| Q2 2019 | $216,000 | -7.7% | 9,581 | -4.8% | 0.00% | – |
| Q1 2019 | $234,000 | -19.9% | 10,063 | -27.6% | 0.00% | – |
| Q4 2018 | $292,000 | +55.3% | 13,908 | +187.7% | 0.00% | – |
| Q3 2018 | $188,000 | +327.3% | 4,835 | +328.3% | 0.00% | – |
| Q2 2018 | $44,000 | -48.8% | 1,129 | -73.4% | 0.00% | – |
| Q1 2018 | $86,000 | +186.7% | 4,245 | +224.5% | 0.00% | – |
| Q4 2017 | $30,000 | -93.7% | 1,308 | -94.8% | 0.00% | – |
| Q3 2017 | $475,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
| SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
| PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
| Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
| EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
| Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
| VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |